UNITED LAB(03933),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

03933 UNITED LAB

Closed 03-23 16:08:09

10.100

-0.380

-3.63%

High10.310	Low9.910	Vol13.39M
Open10.290	D1 Closing10.480	Amplitude3.82%
Mkt Cap19.93B	Tradable Cap19.93B	Total Shares1.97B
T/O134.35M	T/O Rate0.68%	Tradable Shares1.97B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"03933","market":"HK","secType":"STK","nameCN":"UNITED LAB","latestPrice":10.1,"timestamp":1774253289007,"preClose":10.48,"halted":0,"volume":13387900,"delay":0,"changeRate":-0.0362595419847329,"floatShares":1973000000,"shares":1973000000,"eps":1.463938,"marketStatus":"Closed","change":-0.38,"latestTime":"03-23 16:08:09","open":10.29,"high":10.31,"low":9.91,"amount":134346428,"amplitude":0.038168,"askPrice":10.1,"askSize":80000,"bidPrice":10.08,"bidSize":12000,"shortable":3,"etf":0,"ttmEps":1.702,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774315800000},"marketStatusCode":5,"adr":0,"listingDate":1181836800000,"exchange":"SEHK","adjPreClose":10.48,"dividendRate":0.048717,"openAndCloseTimeList":[[1774229400000,1774238400000],[1774242000000,1774252800000]],"volumeRatio":0.961115,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03933","defaultTab":"news","newsList":[{"id":"1196290897","title":"UNITED LAB (03933) Flags 24.8% Profit Drop for FY2025 to Around RMB2.00 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1196290897","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196290897?lang=en_us&edition=fundamental","pubTime":"2026-03-13 12:22","pubTimestamp":1773375739,"startTime":"0","endTime":"0","summary":"Hong Kong, 12 Mar 2026—The United Laboratories International Holdings Limited (UNITED LAB, 03933) issued a profit warning indicating that unaudited consolidated net profit for the year ended 31 Dec...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933"],"gpt_icon":0},{"id":"2619159756","title":"BUZZ-United Laboratories set to drop most in 11 months on forecasting FY profit decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2619159756","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619159756?lang=en_us&edition=fundamental","pubTime":"2026-03-13 10:10","pubTimestamp":1773367821,"startTime":"0","endTime":"0","summary":"BUZZ-United Laboratories set to drop most in 11 months on forecasting FY profit decline** United Laboratories International Holdings 3933.HK slips 10.6% to HK$11.51; set for biggest one-day pct decline since April 7, 2025** Stock hits lowest since February 2; on track for third straight session of declines** Bulk medicine and finished products distributor expects 2025 net profit to drop to 2 bln yuan  from year-ago 2.66 bln yuan profit, citing drop in prices of intermediate products, bulk medicine during the year** YTD, stock up 1%  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nL1N40102N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2618413172","title":"United Laboratories Warns of Lower 2025 Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2618413172","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618413172?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:06","pubTimestamp":1773317187,"startTime":"0","endTime":"0","summary":"The United Laboratories International  expects a profit of 2 billion yuan for the year 2025, down from 2.66 billion yuan a year prior, according to a Thursday filing with the Hong Kong bourse.The pharmaceutical company attributed the forecast to a decline in the market prices of its intermediate products and bulk medicine.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","UBCP","BK4211","03933"],"gpt_icon":0},{"id":"2618139661","title":"BRIEF-United Laboratories International Expects FY2025 Profit Of RMB2 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2618139661","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618139661?lang=en_us&edition=fundamental","pubTime":"2026-03-12 19:25","pubTimestamp":1773314706,"startTime":"0","endTime":"0","summary":"BRIEF-United Laboratories International Expects FY2025 Profit Of RMB2 BillionMarch 12  - United Laboratories International Holdings Ltd 3933.HK:EXPECTS FY2025 PROFIT OF RMB2 BILLIONEXPECTED RESULT DUE TO DECLINE IN MARKET PRICES OF INTERMEDIATE PRODUCTS AND BULK IN FYINTERMEDIATE PRODUCTS SEGMENT PROFIT DOWN RMB1.6 BILLION, BULK MEDICINE DOWN RMB400 MILLION IN 2025Further company coverage: 3933.HK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nFWN4000NP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933","BK1191"],"gpt_icon":0},{"id":"1178154709","title":"UNITED LAB (03933 HK) Issues Profit Warning, Projects 24.7% YoY Decline in 2025 Net Profit to RMB2.00 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1178154709","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178154709?lang=en_us&edition=fundamental","pubTime":"2026-03-12 18:24","pubTimestamp":1773311053,"startTime":"0","endTime":"0","summary":"The United Laboratories International Holdings Limited (UNITED LAB, 03933 HK) announced that, based on unaudited management accounts, the Group expects to post approximately RMB2.00 billion in profit...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933"],"gpt_icon":0},{"id":"1181027229","title":"UNITED LAB Issues Profit Warning, Anticipates 2025 Earnings to Drop to Around 2 Billion Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1181027229","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181027229?lang=en_us&edition=fundamental","pubTime":"2026-03-12 18:14","pubTimestamp":1773310449,"startTime":"0","endTime":"0","summary":"UNITED LAB (03933) has announced that the group expects to achieve a profit of approximately 2 billion yuan in 2025, compared to a profit of about 2.658 billion yuan in 2024. The decrease in profit...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2618389691","title":"TUL expects FY2025 profit of about RMB2 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2618389691","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618389691?lang=en_us&edition=fundamental","pubTime":"2026-03-12 18:07","pubTimestamp":1773310074,"startTime":"0","endTime":"0","summary":"TUL expects profit of about RMB2 billion for the year ended 31 December 2025, versus about RMB2.66 billion in 2024. The company attributed the decline mainly to lower market prices for Intermediate Products, with segment profit down about RMB1.6 billion. Bulk Medicine segment profit fell about RMB0.4 billion, while Finished Products segment profit rose about RMB1.4 billion. The Finished Products increase included about RMB1.3 billion in license fee income from Novo Nordisk A/S.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TUL - The United Laboratories International Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nNDL28jlfX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2618385721","title":"United Laboratories International - Expects FY2025 Profit of RMB2 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2618385721","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618385721?lang=en_us&edition=fundamental","pubTime":"2026-03-12 18:04","pubTimestamp":1773309849,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nFWN4000NP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2618138571","title":"United Laboratories International -  Expected Result Due to Decline in Market Prices of Intermediate Products and Bulk in FY","url":"https://stock-news.laohu8.com/highlight/detail?id=2618138571","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618138571?lang=en_us&edition=fundamental","pubTime":"2026-03-12 18:04","pubTimestamp":1773309849,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nFWN4000NP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2618138466","title":"United Laboratories International - Intermediate Products Segment Profit Down RMB1.6 Bln, Bulk Medicine Down RMB400 Mln in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2618138466","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618138466?lang=en_us&edition=fundamental","pubTime":"2026-03-12 18:04","pubTimestamp":1773309849,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nFWN4000NP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2618641244","title":"United Laboratories' Insulin Injection Receives Marketing Approval in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2618641244","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618641244?lang=en_us&edition=fundamental","pubTime":"2026-03-09 17:23","pubTimestamp":1773048210,"startTime":"0","endTime":"0","summary":"The United Laboratories International (HKG:3933) said it received marketing approval for its insulin injection Degludec in China, according to a Hong Kong bourse filing Monday.The medicine is meant to treat diabetes in adults and can be used as a monotherapy or in combination with other drugs.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["UBCP","03933","BK1191","BK4211"],"gpt_icon":0},{"id":"1150811780","title":"UNITED LAB (03933) Schedules 24 Mar 2026 Board Meeting to Approve FY2025 Results and Discuss Final Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1150811780","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150811780?lang=en_us&edition=fundamental","pubTime":"2026-03-09 16:42","pubTimestamp":1773045777,"startTime":"0","endTime":"0","summary":"The United Laboratories International Holdings Limited (UNITED LAB, stock code: 03933) has announced that its board of directors will convene on 24 March 2026. Key agenda items include: • Approval of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933"],"gpt_icon":0},{"id":"1153681835","title":"UNITED LAB's Insulin Degludec Injection Receives Market Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1153681835","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153681835?lang=en_us&edition=fundamental","pubTime":"2026-03-09 16:40","pubTimestamp":1773045600,"startTime":"0","endTime":"0","summary":"UNITED LAB (03933) announced that its wholly-owned subsidiary, Zhuhai United Laboratories Biopharmaceuticals Co., Ltd., has obtained marketing approval from the National Medical Products...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03933"],"gpt_icon":0},{"id":"2618952646","title":"United Laboratories International - Nmpa Approves Marketing of Insulin Degludec Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2618952646","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618952646?lang=en_us&edition=fundamental","pubTime":"2026-03-09 16:32","pubTimestamp":1773045151,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nFWN3ZU1LK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","03933"],"gpt_icon":0},{"id":"1144810278","title":"UNITED LAB (03933) Announces No Change in Shares for February 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1144810278","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144810278?lang=en_us&edition=fundamental","pubTime":"2026-03-04 17:18","pubTimestamp":1772615926,"startTime":"0","endTime":"0","summary":"The monthly return for the period ended 28 February 2026 shows that UNITED LAB (03933) maintained an authorized share capital of 3.80 billion ordinary shares at a par value of HKD 0.01 each, totaling...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933"],"gpt_icon":0},{"id":"2614292220","title":"A Look At United Laboratories International Holdings (SEHK:3933) Valuation After Positive UBT251 Phase II Obesity Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2614292220","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614292220?lang=en_us&edition=fundamental","pubTime":"2026-02-26 23:30","pubTimestamp":1772119857,"startTime":"0","endTime":"0","summary":"United Laboratories International Holdings (SEHK:3933) and Novo Nordisk have reported Phase 2 data for obesity drug UBT251 in China, with plans to move into Phase 3 locally and to expand global studies.\nSee our latest analysis for United Laboratories International Holdings.\nThe Phase 2 obesity data arrives at a time when the share price has a HK$12.63 latest close and a 3 year total shareholder return above 200%. However, the 1 year total shareholder return of about a 5% decline suggests...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3933/united-laboratories-international-holdings-shares/news/a-look-at-united-laboratories-international-holdings-sehk393","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3933/united-laboratories-international-holdings-shares/news/a-look-at-united-laboratories-international-holdings-sehk393","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","BK1191","UBCP","03933","BK4211"],"gpt_icon":0},{"id":"1158282428","title":"Weight-Loss Drug Developer United Lab Shares Surge as Global Giants Enter Chinese Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1158282428","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158282428?lang=en_us&edition=fundamental","pubTime":"2026-02-25 14:51","pubTimestamp":1772002309,"startTime":"0","endTime":"0","summary":"As competition in the weight-loss drug market intensifies, multinational pharmaceutical giants are increasingly focusing on Chinese assets in this sector. On February 25, after the opening of...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933","BK1191"],"gpt_icon":0},{"id":"2614347778","title":"United Laboratories Reports Positive China Phase 2 Results for Obesity Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2614347778","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614347778?lang=en_us&edition=fundamental","pubTime":"2026-02-25 09:48","pubTimestamp":1771984131,"startTime":"0","endTime":"0","summary":"United Laboratories International (HKG:3933) said its Phase 2 clinical trial of UBT251 Injection, a Class 1 innovative drug developed by its wholly owned unit, has been completed in Chinese patients w","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4211","UBCP","03933","BK1191"],"gpt_icon":0},{"id":"1169113647","title":"The United Laboratories (3933) Completes Phase II Clinical Trial for UBT251 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1169113647","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169113647?lang=en_us&edition=fundamental","pubTime":"2026-02-24 17:04","pubTimestamp":1771923850,"startTime":"0","endTime":"0","summary":"The United Laboratories International Holdings Limited (3933) announced the completion of its Phase II clinical trial for UBT251 Injection in participants with overweight or obesity. According to the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f1cb9c263e4906c971f3030dfa725fa8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933"],"gpt_icon":0},{"id":"2613796115","title":"Triple Agonist Ubt251 Delivers up to 19.7% Mean Weight Loss After 24 Weeks in Phase 2 Trial in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2613796115","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613796115?lang=en_us&edition=fundamental","pubTime":"2026-02-24 17:00","pubTimestamp":1771923618,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f1cb9c263e4906c971f3030dfa725fa8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nTUC86X7WC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03933","BK1191"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tul.com.cn","stockEarnings":[{"period":"1week","weight":-0.0524},{"period":"1month","weight":-0.1676},{"period":"3month","weight":-0.1582},{"period":"6month","weight":-0.3298},{"period":"1year","weight":-0.3382},{"period":"ytd","weight":-0.0958}],"compareEarnings":[{"period":"1week","weight":-0.0074},{"period":"1month","weight":-0.0535},{"period":"3month","weight":-0.0161},{"period":"6month","weight":-0.0478},{"period":"1year","weight":0.0437},{"period":"ytd","weight":-0.0138}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"The United Laboratories International Holdings Limited is an investment holding company principally engaged in the sales of intermediate products, bulk medicine and finished products. The Company operates its business through three segments. The Intermediate Products segment is engaged in the sale of intermediate products. The Bulk Medicine segment is engaged in the sale of bulk medicine. The Finished Products segment is engaged in the sale of antibiotics finished products, non-antibiotics finished products and capsule casings. Through its subsidiaries, the Company is also engaged in the production and sale of organic fertilizer.","yearOnYearQuotes":[{"month":1,"riseRate":0.368421,"avgChangeRate":-0.033088},{"month":2,"riseRate":0.736842,"avgChangeRate":0.076003},{"month":3,"riseRate":0.631579,"avgChangeRate":0.028098},{"month":4,"riseRate":0.611111,"avgChangeRate":0.081119},{"month":5,"riseRate":0.666667,"avgChangeRate":0.040685},{"month":6,"riseRate":0.277778,"avgChangeRate":-0.012388},{"month":7,"riseRate":0.526316,"avgChangeRate":0.011895},{"month":8,"riseRate":0.473684,"avgChangeRate":0.025474},{"month":9,"riseRate":0.421053,"avgChangeRate":-0.006971},{"month":10,"riseRate":0.631579,"avgChangeRate":-0.000903},{"month":11,"riseRate":0.473684,"avgChangeRate":-0.023163},{"month":12,"riseRate":0.421053,"avgChangeRate":0.011153}],"exchange":"SEHK","name":"UNITED LAB","nameEN":"UNITED LAB"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"UNITED LAB(03933),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest UNITED LAB(03933) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"UNITED LAB,03933,UNITED LAB股票,UNITED LAB股票老虎,UNITED LAB股票老虎国际,UNITED LAB行情,UNITED LAB股票行情,UNITED LAB股价,UNITED LAB股市,UNITED LAB股票价格,UNITED LAB股票交易,UNITED LAB股票购买,UNITED LAB股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"UNITED LAB(03933),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest UNITED LAB(03933) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}